Ángel López‐Cuenca

Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

Fabrizio D’Ascenzo, Ovidio De Filippo, Guglielmo Gallone et al. · The Lancet · 2021 · 324 citations

Adverse Events, Health Informatics, Machine Learning +14

Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes

Silvia Montoro‐García, Eduard Shantsila, Luke Tapp et al. · Atherosclerosis · 2013 · 93 citations

Thrombosis, Cardiovascular Disease, Fibrinolytic Status +12

Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes.

Ángel López‐Cuenca, Miríam Gómez-Molina, Pedro J. Flores‐Blanco et al. · PubMed · 2016 · 63 citations · Full text

P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

Ovidio De Filippo, Fabrizio D’Ascenzo, Sergio Raposeiras‐Roubín et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2019 · 51 citations · Full text

Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

Matteo Bianco, Fabrizio D’Ascenzo, Sergio Raposeiras‐Roubín et al. · International Journal of Cardiology · 2019 · 35 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Epidemiology +13